HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Richard Bryce Selected Research
Richard Bryce Research Topics
Disease
17
Breast Neoplasms (Breast Cancer)
01/2022 - 04/2005
8
Neoplasms (Cancer)
11/2021 - 04/2005
3
Diarrhea
07/2019 - 12/2016
2
Neoplasm Metastasis (Metastasis)
01/2021 - 12/2016
2
Disease Progression
01/2020 - 03/2016
2
Nausea
12/2017 - 03/2016
2
Vomiting
12/2017 - 03/2016
1
Constipation
07/2021
1
Fatigue
07/2021
1
Brain Neoplasms (Brain Tumor)
01/2021
1
Noncommunicable Diseases
11/2020
1
Inflammation (Inflammations)
11/2020
1
Central Nervous System Diseases (CNS Diseases)
01/2020
1
Type 2 Diabetes Mellitus (MODY)
09/2017
1
Neutropenia
12/2016
1
Leukopenia
12/2016
1
Myocardial Infarction
03/2016
1
Stomach Neoplasms (Stomach Cancer)
03/2016
1
Multiple Myeloma
09/2012
Drug/Important Bio-Agent (IBA)
18
neratinib
IBA
01/2022 - 03/2016
9
Tyrosine Kinase Inhibitors
IBA
10/2021 - 03/2016
7
Trastuzumab (Herceptin)
FDA Link
10/2019 - 03/2016
5
Lapatinib (GW572016)
FDA Link
11/2021 - 12/2016
3
Fulvestrant (Faslodex)
FDA Link
01/2022 - 01/2019
3
Capecitabine (Xeloda)
FDA Link
11/2021 - 01/2020
2
human ERBB2 protein
IBA
07/2021 - 01/2019
2
Hormones (Hormone)
IBA
01/2021 - 12/2016
2
Circulating Tumor DNA
IBA
10/2020 - 10/2017
2
Mechanistic Target of Rapamycin Complex 1
IBA
10/2020 - 02/2020
2
Phosphotransferases (Kinase)
IBA
01/2020 - 05/2019
2
Paclitaxel (Taxol)
FDA Link
Generic
01/2019 - 12/2016
1
Estrogen Receptors
IBA
01/2022
1
Proteins (Proteins, Gene)
FDA Link
11/2021
1
Biomarkers (Surrogate Marker)
IBA
11/2021
1
ErbB Receptors (EGF Receptor)
IBA
01/2021
1
Inflammasomes
IBA
11/2020
1
DNA (Deoxyribonucleic Acid)
IBA
10/2020
1
Loperamide (Imodium)
FDA Link
Generic
01/2020
1
Afatinib
IBA
05/2019
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
05/2019
1
Gefitinib (Iressa)
FDA Link
05/2019
1
osimertinib
IBA
05/2019
1
Cyclin D1
IBA
01/2019
1
pertuzumab
IBA
01/2019
1
Hemoglobins (Hemoglobin)
IBA
09/2017
1
Pharmaceutical Preparations
IBA
03/2016
1
carfilzomib
IBA
09/2012
1
Proteasome Inhibitors
IBA
09/2012
1
gamma-Linolenic Acid
IBA
04/2005
1
Osteonectin
IBA
04/2005
1
Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
IBA
04/2005
1
Fatty Acids (Saturated Fatty Acids)
IBA
04/2005
Therapy/Procedure
7
Therapeutics
07/2021 - 03/2016
2
Drug Therapy (Chemotherapy)
12/2017 - 03/2016
1
Radiotherapy
01/2021
1
Adjuvant Chemotherapy
12/2017
1
Aftercare (After-Treatment)
09/2012